Gaetani, Lorenzo
Prosperini, Luca
Mancini, Andrea
Eusebi, Paolo
Cerri, Maria Chiara
Pozzilli, Carlo
Calabresi, Paolo
Sarchielli, Paola
Di Filippo, Massimiliano
Article History
Received: 17 May 2018
Revised: 4 August 2018
Accepted: 3 September 2018
First Online: 8 September 2018
Compliance with ethical standards
:
: LG received travel grants from Biogen, Novartis, Teva, Sanofi Genzyme and Almirall to attend national and international conferences. LP has received research grant from Associazione Italiana Sclerosi Multipla (AISM) and Genzyme; consulting and/or lecture fees and travel grants from Biogen, Genzyme, Novartis and Teva. AM received travel grants from Teva and Sanofi Genzyme to attend national conferences. CP has received consulting and/or lecture fees and/or research funding and travel grant from Almirall, Bayer Schering, Biogen Idec, Genzyme, Merck Serono, Novartis, Roche and Teva. PC received/receive research support from Bayer Schering, Biogen-Dompé, Boehringer Ingelheim, Eisai, Lundbeck, Merck-Serono, Novartis, Sanofi-Aventis, Sigma-Tau, and UCB Pharma. MDF participated to advisory boards and received speaker/writing honoraria and funding for traveling from: Bayer, Biogen Idec, Genzyme, Merck, Novartis, Roche and Teva. PE, PS, MCC report no conflicts of interests.